Introduction
Previous UK audits of chronic obstructive pulmonary disease (COPD) undertaken in 1997, 2001 and 2003 (Roberts et al., Reference Roberts, Ryland, Lowe, Kelly, Bucknall and Pearson2002; Royal College of Physicians and British Thoracic Society, 2003; Royal College of Physicians, British Thoracic Society and British Lung Foundation, 2003) examined the organisation and quality of acute hospital services but did not engage patient opinion or extend their scope into primary care. Given this context, we undertook surveys of patients, General Practitioners and Primary Care Organisations within the 2008 UK COPD audit to understand more about the organisation of community services and the impact COPD has upon these groups. We wished in particular to assess the period before hospitalisation, when patients noticed the symptoms of exacerbation and how they accessed care. Specifically, we wanted to obtain data from patients that might inform the development of self-care and community COPD services around the prevention of hospital admission. We present here some results from the patient questionnaire with specific reference to understanding of disease, accessing care, self-management and oxygen/nebuliser use.
Methods
Methodology and reports of the 2008 National COPD Audit have been published elsewhere (Royal College of Physicians, British Thoracic Society and British Lung Foundation reports, 2008a; 2008b; 2008c; 2008d; 2008e). UK hospital units admitting unselected emergency medical admissions were asked to identify prospectively up to 60 consecutive cases of COPD exacerbation between March and May 2008, and then to audit retrospectively their in-hospital care and outcomes 90 days following the index admission. Acute hospital teams were asked to request 30 of these patients to complete a survey about their COPD as they approached discharge from hospital. Survey responses were returned directly to the Project Team at the Clinical Effectiveness and Evaluation Unit (CEEU) within pre-paid envelopes. It is not known exactly how many survey questionnaires were used, and consequently the response rate was estimated using an assumed denominator made up of 30 discharges each for units with at least 30 discharges in the clinical audit, and all discharges for units with fewer than 30 discharges.
The patient questionnaire comprised 21 questions (available at http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/ncrop/Pages/Resources.aspx, see Appendix A). It was compiled following consultation with multidisciplinary professional groups and patients attending support meetings run by the British Lung Foundation (BLF). It was designed to determine how patients access COPD care, to understand their use of primary care services in the period leading up to hospitalisation with exacerbation, to assess how patients self-manage their condition, which patients might benefit from enhanced case management and the potential for interventions to prevent hospital admission.
Fisher's exact test was used to compare between survey responses of patients stating they used both oxygen and nebuliser at home and survey responses of other patients.
Results
In the clinical audit 9716 cases of exacerbation were submitted by 232 NHS hospital units taking acute COPD admissions, an estimated unit participation of 97%. A total of 2861 analysable patient survey returns were received from 221 units (median 13, IQR 8–17 per unit), the estimated response being 46% (2861/6255). Gender was not stated by 198 (7%) patients but, when known, 1314 (49%) were female and 1349 (51%) were male. Mean age was 72 years (males 71 years, females 72 years, gender not stated 71 years). Just over one-third of patients (1043, 36%) lived alone without support (30% male, 44% female). Nearly all patients (2369, 83%) reported having flare-ups of their chest condition a number of times a year, while 905 (32%) were using oxygen and 1386 (48%) were using nebulisers at home.
Reported understanding of COPD was good, 85% of patients stating they knew what COPD stood for and 79% knowing they had it before the admission (Table 1). Stated understanding of medications was also very good (81%) and 68% of patients reported infection occurring in the month prior to their admission. Just over half (57%) of these cases also noticed a change in the colour or amount of sputum but, importantly, this change was often noticed several days before hospitalisation (Table 2). Only 23% of patients had been given a written plan for what to do when bad (Table 1) despite stated attendance at either the GP surgery (55%) or chest clinic (42%).
COPD = chronic obstructive pulmonary disease.
Prior to this episode, most of these patients (60%) had been admitted to hospital within the last year and a total of 74% had been previously admitted at some time (Table 3). However, less than half were likely to see their General Practitioner (GP) immediately or the Practice Nurse when their chest was bad and contact with respiratory nurses (9%) was particularly low (Table 4). Only one-third of patients saw their GP prior to the current admission, with 53% going to Accident & Emergency (A&E) directly and another 16% getting to hospital by other means. When their chest was getting bad, 1640 (57%) said they would seek advice over the phone from their GP, respiratory nurse or hospital doctor. A quarter of such patients (428, 26%) had direct telephone access to professional advice and another 889 (54%) felt they were able to get telephone advice the same day but some 323 (20%) felt either that it would take longer than this or were not sure.
COPD = chronic obstructive pulmonary disease.
COPD = chronic obstructive pulmonary disease.
aPatients often selected more than one option, these depending mainly on how severe their chest was.
bPatients could choose as many options as applied to their situation.
cOther included situations such as spouse called ambulance, family member called ambulance, warden called ambulance, doctor advised patient to call ambulance but did not see patient, helpline advised patient to call ambulance, care-line advised patient to call ambulance, out of hours service sent patient to hospital, paramedics sent patient to hospital, admitted via clinic, saw GP and treated but needed admission at a later stage.
Both oxygen and nebulised bronchodilator were used at home by 675 (24%) patients (Table 5). Almost all (92%) of these 675 cases had been admitted with COPD exacerbation previously, and 520 (77%) reported an admission within the previous 12 months. More patients in this group described frequent exacerbation (94% versus 79%) yet there was little difference in the proportion given a written plan for managing exacerbation (29% versus 21%). Although more patients on oxygen and nebulisers knew they had COPD prior to the recent admission (91% versus 75%), stated understanding of COPD was not greatly different (88% versus 84%) and only 29% of those previously admitted had rescue medication at home compared to 22% of the rest. The oxygen and nebuliser patients were more aware of changes in sputum (63% versus 56%).
COPD = chronic obstructive pulmonary disease; NHS = National Health Service.
aFishers exact test.
Patients using oxygen and nebulisers (Table 5) seemed better at accessing respiratory nurses during exacerbation (16% versus 6%) and were less likely to wait before seeking help (22% versus 31%). A greater proportion called an ambulance before the admission (47% versus 39%) and more sought telephone advice (75% versus 52%). Of these, more had a direct access number to phone (33% versus 23%). For those without direct access, more from this group felt they could obtain telephone advice the same day (80% versus 71%).
Discussion
Main findings
To our knowledge, this is the first national survey enquiring about COPD care in the period leading up to an acute hospital admission. The data show such a study of COPD patients is feasible and can yield helpful information from a large number of cases. The responses suggest a population that uses a lot of healthcare resources, has severe and frequently exacerbating COPD. Most patients knew they had COPD, knew what it was and had been in hospital with exacerbation before. Although patients reported good understanding of disease, symptoms were often present for some time prior to admission. Infection was a frequent event in the month before admission and there was often a period of sputum production prior to presentation with exacerbation. Self-management of exacerbation seemed low, despite 55% receiving regular review at surgery and 42% in hospital chest clinics. When sick, patients tended to use hospital services instead of primary care and came to hospital by various means. Few patients used specialist nurses as a source of support, and access to telephone advice was patchy, even for patients on oxygen and/or nebulisers. Many patients used oxygen and nebulisers and this group seemed at particular risk of admission.
Limitations
There are several limitations to our study, the first being the survey was undertaken in 2008. However, we have no reason or evidence to suggest the findings would be any different now, the need to improve self-care, recognition and management of exacerbation being highlighted in recent documents published by both the Department of Health in England (DH, 2011) and National Institute of Health and Clinical Excellence (NICE, 2011). Second, while it may have been entirely appropriate for patients to take themselves to hospital rather than use community services at the time of survey, we did not ask why they did so and neither did we enquire about the timing of admission. A better understanding of data reliability could have been achieved by calculating kappa values, having asked a second researcher to review sample responses, and we would intend to do this in future surveys. Neither did we link individual spirometric data to survey responses although these were all cases from the clinical audit, in which mean % predicted FEV1 was 38% (Royal College of Physicians, British Thoracic Society and British Lung Foundation reports, 2008a; 2008b; 2008c; 2008d; 2008e).
Significance of findings
The data suggest we need to help patients improve their recognition of exacerbation, self-care and access to healthcare advice. Although the best method, timing or setting is not established, self-management education in COPD patients is associated with a reduction in hospital admissions without affecting other outcome parameters (Bourbeau et al., Reference Bourbeau, Julien, Maltais, Rouleau, Beaupre, Begin, Renzi, Nault, Borycki, Schwartzman, Singh and Collet2003; Effing et al., Reference Effing, Monninkhof, van der Valk, van der Palen, van Herwaarden, Partridge, Walters and Zielhuis2007). Seemungal et al. (Reference Seemungal, Donaldson, Bhowmik, Jeffries and Wedzicha2000) demonstrated a subtle rise in symptoms in the period prior to onset of exacerbation and our data also imply there should be an emphasis upon recognising infection as a potential trigger for exacerbation, prompting action when sputum changes occur. Notably, only a quarter of our patients had access to rescue medication at home, yet COPD education delivered in primary care, taking as little as 2 h, increases objective measures of disease-specific knowledge (Hill et al., Reference Hill, Mangovski-Alzamora, Guyatt, Heels Ansdell, Bragaglia, Tamari, Jones and Goldstein2010); it would seem reasonable to suggest such packages include specific advice about the recognition of exacerbation, how to act at its onset, what medication is effective, how to use it and how to access advice.
It was also unclear why so few patients normally contacted a respiratory nurse during exacerbation. Only 57% of our cohort sought telephone advice but recent evidence suggests such a service may reduce hospital admission (Robert et al., Reference Robert, Leeder and Robinson2008). Nurse-led telephone and self-management advice reduces unscheduled visits and mortality in patients recently admitted with COPD exacerbation (Sridhar et al., Reference Sridhar, Taylor, Dawson, Roberts and Partridge2008). Nurse-led clinics are reported to reduce exacerbation rates (Rootmensen et al., Reference Rootmensen, van Keimpema, Looysen, van der Schaaf, de Haan and Jansen2008).
There is also scope for better communication, co-ordination and sharing of advice between primary and secondary care services, given that many patients were attending for review at both their GP surgery and a chest clinic. This would seem particularly true of patients receiving oxygen and nebulisers, of whom 77% had been admitted to hospital within the previous 12 months; a more consistent approach to case-managing this most vulnerable of groups would seem sensible. Although we did not investigate the reasons for such high admission rates in these patients, they reported having significantly more exacerbations and a greater propensity to seek telephone advice, yet had similar levels of self-management and access to care as the rest of the population. Many groups are developing strategies that place admission avoidance at their heart and have developed community COPD teams for this purpose (Royal College of Physicians, British Thoracic Society and British Lung Foundation reports, 2008a; 2008b; 2008c; 2008d; 2008e). Our data suggest interface services that integrate well with the primary and secondary care teams, but also put self-care, patient education and case-management of the most vulnerable at their core, would be beneficial. As yet, however, there is limited evidence in the United Kingdom to suggest interface services are looking to broader strategic issues and local educational needs (Pinnock et al., Reference Pinnock, Huby, Tierney, Hamilton, Powell, Kielmann and Sheikh2009).
Future work
There is much to be explored as a consequence of this work. Given the data suggest patients may avoid hospital admission by acting promptly when sputum changes occur, the formal assessment of a self-care plan that places identification of sputum change at its heart would be useful. The high use of primary care services in the period leading up to hospital admission also implies COPD patients need better-planned links into the wider care process and improved access to rapid advice from healthcare professionals, particularly nurses. It would be valuable to study the specific effect of an available ‘named contact’ on hospital admissions and to undertake a systematic evaluation of enhanced case-management (eg by Tele-Health) for those with the most severe disease, that is, patients on oxygen and nebulisers. Further study of the precise reasons for admission in this group would be useful.
Future surveys would benefit from exploring in greater detail the nature of patients’ understanding of disease and self-care, and specifically to ask whether they enacted a plan that failed or felt their plan was insufficient. Although patient-reported understanding of disease and medication was very good (Table 1), it would be of interest to consider the 15% who did not know what COPD stood for, the 21% who did not know they had it before their admission and the 19% whose stated understanding was not very good and to study the relationships between these groups, patient outcomes and use of healthcare resource.
Acknowledgements
The 2008 UK COPD audit was supported by a grant from the Health Foundation.